Whole-exome cfDNA profiling captures the mutational signatures of metastatic breast cancer for monitoring disease evolution
Abstract
Background: Whole-exome sequencing of plasma cell-free DNA (WES-cfDNA) is an emerging liquid biopsy approach for identification of somatic mutations and yields high-concordance when compared to WES of the tumours of patients with advanced disease. Here we show that sequential WES-cfDNA provides insight regarding the evolution of metastatic breast cancer and that global mutation profiles relate to clinical response and progression to different...
Paper Details
Title
Whole-exome cfDNA profiling captures the mutational signatures of metastatic breast cancer for monitoring disease evolution
Published Date
Oct 1, 2018
Journal
Volume
29
Pages
viii652 - viii652
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History